Skip to main content
. 2020 Feb 21;15(2):e0229377. doi: 10.1371/journal.pone.0229377

Fig 2. The change of eGFR at acute phase after cisplatin administration.

Fig 2

An unpaired t-test was performed to compare the percentages of eGFR decline in users and non-users of DPP-4 inhibitors. Data are presented as mean ± SD.